Mersana Therapeutics Stock Market Value
| MRSN Stock | USD 3.25 0.09 2.69% |
| Symbol | Mersana |
Mersana Therapeutics Price To Book Ratio
Is Mersana Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mersana Therapeutics. If investors know Mersana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mersana Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 0.317 | Quarterly Revenue Growth (0.27) | Return On Assets (0.38) | Return On Equity (2.66) |
The market value of Mersana Therapeutics is measured differently than its book value, which is the value of Mersana that is recorded on the company's balance sheet. Investors also form their own opinion of Mersana Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mersana Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mersana Therapeutics' market value can be influenced by many factors that don't directly affect Mersana Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mersana Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mersana Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mersana Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mersana Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mersana Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mersana Therapeutics.
| 07/27/2023 |
| 04/22/2024 |
If you would invest 0.00 in Mersana Therapeutics on July 27, 2023 and sell it all today you would earn a total of 0.00 from holding Mersana Therapeutics or generate 0.0% return on investment in Mersana Therapeutics over 270 days. Mersana Therapeutics is related to or competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, Inozyme PharmaInc, X4 Pharmaceuticals, Day One, and Hookipa Pharma. Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates for cancer pat... More
Mersana Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mersana Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mersana Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.1 | |||
| Information Ratio | 0.0436 | |||
| Maximum Drawdown | 30.55 | |||
| Value At Risk | (9.15) | |||
| Potential Upside | 9.93 |
Mersana Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mersana Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mersana Therapeutics' standard deviation. In reality, there are many statistical measures that can use Mersana Therapeutics historical prices to predict the future Mersana Therapeutics' volatility.| Risk Adjusted Performance | 0.045 | |||
| Jensen Alpha | 0.1393 | |||
| Total Risk Alpha | (0.36) | |||
| Sortino Ratio | 0.0472 | |||
| Treynor Ratio | 0.1348 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mersana Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mersana Therapeutics Backtested Returns
Mersana Therapeutics appears to be very risky, given 3 months investment horizon. Mersana Therapeutics has Sharpe Ratio of 0.04, which conveys that the firm had a 0.04% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Mersana Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Mersana Therapeutics' Risk Adjusted Performance of 0.045, mean deviation of 3.91, and Downside Deviation of 5.1 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Mersana Therapeutics holds a performance score of 3. The company secures a Beta (Market Risk) of 2.34, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mersana Therapeutics will likely underperform. Please check Mersana Therapeutics' value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Mersana Therapeutics' current price movements will revert.
Auto-correlation | 0.34 |
Below average predictability
Mersana Therapeutics has below average predictability. Overlapping area represents the amount of predictability between Mersana Therapeutics time series from 27th of July 2023 to 9th of December 2023 and 9th of December 2023 to 22nd of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mersana Therapeutics price movement. The serial correlation of 0.34 indicates that nearly 34.0% of current Mersana Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.34 | |
| Spearman Rank Test | 0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 1.24 |
Mersana Therapeutics lagged returns against current returns
Autocorrelation, which is Mersana Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Mersana Therapeutics' stock expected returns. We can calculate the autocorrelation of Mersana Therapeutics returns to help us make a trade decision. For example, suppose you find that Mersana Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Mersana Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Mersana Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Mersana Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Mersana Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Mersana Therapeutics Lagged Returns
When evaluating Mersana Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Mersana Therapeutics stock have on its future price. Mersana Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Mersana Therapeutics autocorrelation shows the relationship between Mersana Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Mersana Therapeutics.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mersana Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mersana Therapeutics' short interest history, or implied volatility extrapolated from Mersana Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Mersana Therapeutics Correlation, Mersana Therapeutics Volatility and Mersana Therapeutics Alpha and Beta module to complement your research on Mersana Therapeutics. To learn how to invest in Mersana Stock, please use our How to Invest in Mersana Therapeutics guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Mersana Stock analysis
When running Mersana Therapeutics' price analysis, check to measure Mersana Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mersana Therapeutics is operating at the current time. Most of Mersana Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mersana Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mersana Therapeutics' price. Additionally, you may evaluate how the addition of Mersana Therapeutics to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Mersana Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.